サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1428823

アファメラノチドの世界市場に関する洞察、2030年までの予測

Global Afamelanotide Market Insights, Forecast to 2030
出版日: | 発行: QYResearch | ページ情報: 英文 75 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アファメラノチドの世界市場に関する洞察、2030年までの予測
出版日: 2024年02月21日
発行: QYResearch
ページ情報: 英文 75 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、アファメラノチド (Afamelanotide) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • アファメラノチドの製品概要
  • 市場：タイプ別
    • 世界のアファメラノチドの市場規模成長率：タイプ別, 2019 VS 2023 VS 2030
    • SFM Implantation Cannula
    • other implantation devices
  • 市場：用途別
    • 世界のアファメラノチドの市場規模成長率：用途別, 2019 VS 2023 VS 2030
    • Chemical
    • Medical
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のアファメラノチド 売上予測・予想 2019-2030
  • 世界のアファメラノチドの収益：地域別
    • 世界のアファメラノチドの収益：地域別: 2019 VS 2023 VS 2030
    • 世界のアファメラノチドの収益：地域別 (2019-2024)
    • 世界のアファメラノチドの収益：地域別 (2025-2030)
    • 世界のアファメラノチドの収益市場シェア 地域別 (2019-2030)
  • 世界のアファメラノチド 売上予測・予想 2019-2030
  • 世界のアファメラノチドの販売：地域別
    • 世界のアファメラノチドの販売：地域別: 2019 VS 2023 VS 2030
    • 世界のアファメラノチドの販売：地域別 (2019-2024)
    • 世界のアファメラノチドの販売：地域別 (2025-2030)
    • 世界のアファメラノチドの販売市場シェア 地域別 (2019-2030)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界のアファメラノチドの販売：企業別
    • 世界のアファメラノチドの販売：企業別 (2019-2024)
    • 世界のアファメラノチドの販売市場シェア：企業別 (2019-2024)
    • 世界の上位10・上位5企業： アファメラノチド in 2023
  • 世界のアファメラノチドの収益：企業別
    • 世界のアファメラノチドの収益：企業別 (2019-2024)
    • 世界のアファメラノチドの収益市場シェア：企業別 (2019-2024)
    • 世界の上位10・上位5企業： アファメラノチドの収益 2023
  • 世界の主要企業 アファメラノチド, 業界ランキング, 2022 VS 2023 VS 2024
  • 世界のアファメラノチドの販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界のアファメラノチドの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー アファメラノチド, 製造拠点分布と本社
  • 世界の主要メーカー アファメラノチド, 提供製品と用途
  • 世界の主要メーカー アファメラノチド, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界のアファメラノチドの販売：タイプ別
    • 世界のアファメラノチドの販売実績：タイプ別 (2019-2024)
    • 世界のアファメラノチドの販売予測：タイプ別 (2025-2030)
    • 世界のアファメラノチドの販売市場シェア：タイプ別 (2019-2030)
  • 世界のアファメラノチド 収益：タイプ別
    • 世界のアファメラノチドの収益実績：タイプ別 (2019-2024)
    • 世界のアファメラノチドの収益予測：タイプ別 (2025-2030)
    • 世界のアファメラノチドの収益市場シェア：タイプ別 (2019-2030)
  • 世界のアファメラノチドの価格：タイプ別
    • 世界のアファメラノチドの価格：タイプ別 (2019-2024)
    • 世界のアファメラノチドの価格予測：タイプ別 (2025-2030)

第5章 市場規模：用途別

  • 世界のアファメラノチドの販売：用途別
    • 世界のアファメラノチドの販売実績：用途別 (2019-2024)
    • 世界のアファメラノチドの販売予測：用途別 (2025-2030)
    • 世界のアファメラノチドの販売市場シェア：用途別 (2019-2030)
  • 世界のアファメラノチドの収益：用途別
    • 世界のアファメラノチドの収益実績：用途別 (2019-2024)
    • 世界のアファメラノチドの収益予測：用途別 (2025-2030)
    • 世界のアファメラノチドの収益市場シェア：用途別 (2019-2030)
  • 世界のアファメラノチドの価格：用途別
    • 世界のアファメラノチドの価格：用途別 (2019-2024)
    • 世界のアファメラノチドの価格予測：用途別 (2025-2030)

第6章 米国・カナダ

  • 米国・カナダ アファメラノチド 市場規模：タイプ別
    • 米国・カナダ アファメラノチドの販売：タイプ別 (2019-2030)
    • 米国・カナダ アファメラノチド 収益：タイプ別 (2019-2030)
  • 米国・カナダ アファメラノチド 市場規模：用途別
    • 米国・カナダ アファメラノチドの販売：用途別 (2019-2030)
    • 米国・カナダ アファメラノチドの収益：用途別 (2019-2030)
  • 米国・カナダ アファメラノチド 市場規模：国別
    • 米国・カナダ アファメラノチドの収益：国別: 2019 VS 2023 VS 2030
    • 米国・カナダ アファメラノチドの販売：国別 (2019-2030)
    • 米国・カナダ アファメラノチドの収益：国別 (2019-2030)
    • US
    • カナダ

第7章 欧州

  • 欧州のアファメラノチド 市場規模：タイプ別
    • 欧州のアファメラノチドの販売：タイプ別 (2019-2030)
    • 欧州のアファメラノチド 収益：タイプ別 (2019-2030)
  • 欧州のアファメラノチド 市場規模：用途別
    • 欧州のアファメラノチドの販売：用途別 (2019-2030)
    • 欧州のアファメラノチドの収益：用途別 (2019-2030)
  • 欧州のアファメラノチド 市場規模：国別
    • 欧州のアファメラノチドの収益：国別: 2019 VS 2023 VS 2030
    • 欧州のアファメラノチドの販売：国別 (2019-2030)
    • 欧州のアファメラノチドの収益：国別 (2019-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国のアファメラノチド 市場規模
    • 中国のアファメラノチド 売上 (2019-2030)
    • 中国のアファメラノチド 収益 (2019-2030)
  • 中国のアファメラノチド 市場規模：用途別
    • 中国のアファメラノチドの販売：用途別 (2019-2030)
    • 中国のアファメラノチドの収益：用途別 (2019-2030)

第9章 アジア（中国を除く）

  • アジア地域 アファメラノチド 市場規模：タイプ別
    • アジア地域 アファメラノチドの販売：タイプ別 (2019-2030)
    • アジア地域 アファメラノチド 収益：タイプ別 (2019-2030)
  • アジア地域 アファメラノチド 市場規模：用途別
    • アジア地域 アファメラノチドの販売：用途別 (2019-2030)
    • アジア地域 アファメラノチドの収益：用途別 (2019-2030)
  • アジア地域 アファメラノチドの販売：地域別
    • アジア地域 アファメラノチドの収益：地域別: 2019 VS 2023 VS 2030
    • アジア地域 アファメラノチドの収益：地域別 (2019-2030)
    • アジア地域 アファメラノチドの販売：地域別 (2019-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカのアファメラノチド 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカのアファメラノチドの販売：タイプ別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカのアファメラノチド 収益：タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカのアファメラノチド 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカのアファメラノチドの販売：用途別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカのアファメラノチドの収益：用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカのアファメラノチドの販売：国別
    • 中東, アフリカ ・ラテンアメリカのアファメラノチドの収益：国別: 2019 VS 2023 VS 2030
    • 中東, アフリカ ・ラテンアメリカのアファメラノチドの収益：国別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカのアファメラノチドの販売：国別 (2019-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Clinuvel Pharmaceuticals
  • Aspen API
  • Jin Dun Medical
  • Winhealth Pharma

第12章 業界チェーンと販売チャネルの分析

  • アファメラノチド 業界チェーン分析
  • アファメラノチド 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • アファメラノチド 生産形態とプロセス
  • アファメラノチド 販売およびマーケティング
    • アファメラノチド 販売チャネルs
    • アファメラノチド 卸業者
  • アファメラノチド 顧客

第13章 市場動向

  • アファメラノチド 業界動向
  • アファメラノチド 市場の促進要因
  • アファメラノチド 市場の課題
  • アファメラノチド 市場の抑制要因

第14章 主な調査結果 世界のアファメラノチドの主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Afamelanotide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 2. Major Manufacturers of SFM Implantation Cannula
  • Table 3. Major Manufacturers of other implantation devices
  • Table 4. Global Afamelanotide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 5. Global Afamelanotide Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 6. Global Afamelanotide Revenue by Region (2019-2024) & (US$ Million)
  • Table 7. Global Afamelanotide Revenue by Region (2025-2030) & (US$ Million)
  • Table 8. Global Afamelanotide Revenue Market Share by Region (2019-2024)
  • Table 9. Global Afamelanotide Revenue Market Share by Region (2025-2030)
  • Table 10. Global Afamelanotide Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 11. Global Afamelanotide Sales by Region (2019-2024) & (K Units)
  • Table 12. Global Afamelanotide Sales by Region (2025-2030) & (K Units)
  • Table 13. Global Afamelanotide Sales Market Share by Region (2019-2024)
  • Table 14. Global Afamelanotide Sales Market Share by Region (2025-2030)
  • Table 15. Global Afamelanotide Sales by Manufacturers (2019-2024) & (K Units)
  • Table 16. Global Afamelanotide Sales Share by Manufacturers (2019-2024)
  • Table 17. Global Afamelanotide Revenue by Manufacturers (2019-2024) & (US$ Million)
  • Table 18. Global Afamelanotide Revenue Share by Manufacturers (2019-2024)
  • Table 19. Global Key Players of Afamelanotide, Industry Ranking, 2022 VS 2023 VS 2024
  • Table 20. Afamelanotide Price by Manufacturers 2019-2024 (US$/Unit)
  • Table 21. Global Afamelanotide Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Afamelanotide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Afamelanotide as of 2023)
  • Table 23. Global Key Manufacturers of Afamelanotide, Manufacturing Base Distribution and Headquarters
  • Table 24. Global Key Manufacturers of Afamelanotide, Product Offered and Application
  • Table 25. Global Key Manufacturers of Afamelanotide, Date of Enter into This Industry
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Afamelanotide Sales by Type (2019-2024) & (K Units)
  • Table 28. Global Afamelanotide Sales by Type (2025-2030) & (K Units)
  • Table 29. Global Afamelanotide Sales Share by Type (2019-2024)
  • Table 30. Global Afamelanotide Sales Share by Type (2025-2030)
  • Table 31. Global Afamelanotide Revenue by Type (2019-2024) & (US$ Million)
  • Table 32. Global Afamelanotide Revenue by Type (2025-2030) & (US$ Million)
  • Table 33. Global Afamelanotide Revenue Share by Type (2019-2024)
  • Table 34. Global Afamelanotide Revenue Share by Type (2025-2030)
  • Table 35. Afamelanotide Price by Type (2019-2024) & (US$/Unit)
  • Table 36. Global Afamelanotide Price Forecast by Type (2025-2030) & (US$/Unit)
  • Table 37. Global Afamelanotide Sales by Application (2019-2024) & (K Units)
  • Table 38. Global Afamelanotide Sales by Application (2025-2030) & (K Units)
  • Table 39. Global Afamelanotide Sales Share by Application (2019-2024)
  • Table 40. Global Afamelanotide Sales Share by Application (2025-2030)
  • Table 41. Global Afamelanotide Revenue by Application (2019-2024) & (US$ Million)
  • Table 42. Global Afamelanotide Revenue by Application (2025-2030) & (US$ Million)
  • Table 43. Global Afamelanotide Revenue Share by Application (2019-2024)
  • Table 44. Global Afamelanotide Revenue Share by Application (2025-2030)
  • Table 45. Afamelanotide Price by Application (2019-2024) & (US$/Unit)
  • Table 46. Global Afamelanotide Price Forecast by Application (2025-2030) & (US$/Unit)
  • Table 47. US & Canada Afamelanotide Sales by Type (2019-2024) & (K Units)
  • Table 48. US & Canada Afamelanotide Sales by Type (2025-2030) & (K Units)
  • Table 49. US & Canada Afamelanotide Revenue by Type (2019-2024) & (US$ Million)
  • Table 50. US & Canada Afamelanotide Revenue by Type (2025-2030) & (US$ Million)
  • Table 51. US & Canada Afamelanotide Sales by Application (2019-2024) & (K Units)
  • Table 52. US & Canada Afamelanotide Sales by Application (2025-2030) & (K Units)
  • Table 53. US & Canada Afamelanotide Revenue by Application (2019-2024) & (US$ Million)
  • Table 54. US & Canada Afamelanotide Revenue by Application (2025-2030) & (US$ Million)
  • Table 55. US & Canada Afamelanotide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 56. US & Canada Afamelanotide Revenue by Country (2019-2024) & (US$ Million)
  • Table 57. US & Canada Afamelanotide Revenue by Country (2025-2030) & (US$ Million)
  • Table 58. US & Canada Afamelanotide Sales by Country (2019-2024) & (K Units)
  • Table 59. US & Canada Afamelanotide Sales by Country (2025-2030) & (K Units)
  • Table 60. Europe Afamelanotide Sales by Type (2019-2024) & (K Units)
  • Table 61. Europe Afamelanotide Sales by Type (2025-2030) & (K Units)
  • Table 62. Europe Afamelanotide Revenue by Type (2019-2024) & (US$ Million)
  • Table 63. Europe Afamelanotide Revenue by Type (2025-2030) & (US$ Million)
  • Table 64. Europe Afamelanotide Sales by Application (2019-2024) & (K Units)
  • Table 65. Europe Afamelanotide Sales by Application (2025-2030) & (K Units)
  • Table 66. Europe Afamelanotide Revenue by Application (2019-2024) & (US$ Million)
  • Table 67. Europe Afamelanotide Revenue by Application (2025-2030) & (US$ Million)
  • Table 68. Europe Afamelanotide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 69. Europe Afamelanotide Revenue by Country (2019-2024) & (US$ Million)
  • Table 70. Europe Afamelanotide Revenue by Country (2025-2030) & (US$ Million)
  • Table 71. Europe Afamelanotide Sales by Country (2019-2024) & (K Units)
  • Table 72. Europe Afamelanotide Sales by Country (2025-2030) & (K Units)
  • Table 73. China Afamelanotide Sales by Type (2019-2024) & (K Units)
  • Table 74. China Afamelanotide Sales by Type (2025-2030) & (K Units)
  • Table 75. China Afamelanotide Revenue by Type (2019-2024) & (US$ Million)
  • Table 76. China Afamelanotide Revenue by Type (2025-2030) & (US$ Million)
  • Table 77. China Afamelanotide Sales by Application (2019-2024) & (K Units)
  • Table 78. China Afamelanotide Sales by Application (2025-2030) & (K Units)
  • Table 79. China Afamelanotide Revenue by Application (2019-2024) & (US$ Million)
  • Table 80. China Afamelanotide Revenue by Application (2025-2030) & (US$ Million)
  • Table 81. Asia Afamelanotide Sales by Type (2019-2024) & (K Units)
  • Table 82. Asia Afamelanotide Sales by Type (2025-2030) & (K Units)
  • Table 83. Asia Afamelanotide Revenue by Type (2019-2024) & (US$ Million)
  • Table 84. Asia Afamelanotide Revenue by Type (2025-2030) & (US$ Million)
  • Table 85. Asia Afamelanotide Sales by Application (2019-2024) & (K Units)
  • Table 86. Asia Afamelanotide Sales by Application (2025-2030) & (K Units)
  • Table 87. Asia Afamelanotide Revenue by Application (2019-2024) & (US$ Million)
  • Table 88. Asia Afamelanotide Revenue by Application (2025-2030) & (US$ Million)
  • Table 89. Asia Afamelanotide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 90. Asia Afamelanotide Revenue by Region (2019-2024) & (US$ Million)
  • Table 91. Asia Afamelanotide Revenue by Region (2025-2030) & (US$ Million)
  • Table 92. Asia Afamelanotide Sales by Region (2019-2024) & (K Units)
  • Table 93. Asia Afamelanotide Sales by Region (2025-2030) & (K Units)
  • Table 94. Middle East, Africa and Latin America Afamelanotide Sales by Type (2019-2024) & (K Units)
  • Table 95. Middle East, Africa and Latin America Afamelanotide Sales by Type (2025-2030) & (K Units)
  • Table 96. Middle East, Africa and Latin America Afamelanotide Revenue by Type (2019-2024) & (US$ Million)
  • Table 97. Middle East, Africa and Latin America Afamelanotide Revenue by Type (2025-2030) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Afamelanotide Sales by Application (2019-2024) & (K Units)
  • Table 99. Middle East, Africa and Latin America Afamelanotide Sales by Application (2025-2030) & (K Units)
  • Table 100. Middle East, Africa and Latin America Afamelanotide Revenue by Application (2019-2024) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Afamelanotide Revenue by Application (2025-2030) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Afamelanotide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 103. Middle East, Africa and Latin America Afamelanotide Revenue by Country (2019-2024) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Afamelanotide Revenue by Country (2025-2030) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Afamelanotide Sales by Country (2019-2024) & (K Units)
  • Table 106. Middle East, Africa and Latin America Afamelanotide Sales by Country (2025-2030) & (K Units)
  • Table 107. Clinuvel Pharmaceuticals Company Information
  • Table 108. Clinuvel Pharmaceuticals Description and Major Businesses
  • Table 109. Clinuvel Pharmaceuticals Afamelanotide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 110. Clinuvel Pharmaceuticals Afamelanotide Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. Clinuvel Pharmaceuticals Recent Developments
  • Table 112. Aspen API Company Information
  • Table 113. Aspen API Description and Major Businesses
  • Table 114. Aspen API Afamelanotide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 115. Aspen API Afamelanotide Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Aspen API Recent Developments
  • Table 117. Jin Dun Medical Company Information
  • Table 118. Jin Dun Medical Description and Major Businesses
  • Table 119. Jin Dun Medical Afamelanotide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 120. Jin Dun Medical Afamelanotide Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Jin Dun Medical Recent Developments
  • Table 122. Winhealth Pharma Company Information
  • Table 123. Winhealth Pharma Description and Major Businesses
  • Table 124. Winhealth Pharma Afamelanotide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 125. Winhealth Pharma Afamelanotide Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Winhealth Pharma Recent Developments
  • Table 127. Key Raw Materials Lists
  • Table 128. Raw Materials Key Suppliers Lists
  • Table 129. Afamelanotide Distributors List
  • Table 130. Afamelanotide Customers List
  • Table 131. Afamelanotide Market Trends
  • Table 132. Afamelanotide Market Drivers
  • Table 133. Afamelanotide Market Challenges
  • Table 134. Afamelanotide Market Restraints
  • Table 135. Research Programs/Design for This Report
  • Table 136. Key Data Information from Secondary Sources
  • Table 137. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Afamelanotide Product Picture
  • Figure 2. Global Afamelanotide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 3. Global Afamelanotide Market Share by Type in 2023 & 2030
  • Figure 4. SFM Implantation Cannula Product Picture
  • Figure 5. other implantation devices Product Picture
  • Figure 6. Global Afamelanotide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 7. Global Afamelanotide Market Share by Application in 2023 & 2030
  • Figure 8. Chemical
  • Figure 9. Medical
  • Figure 10. Afamelanotide Report Years Considered
  • Figure 11. Global Afamelanotide Revenue, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 12. Global Afamelanotide Revenue 2019-2030 (US$ Million)
  • Figure 13. Global Afamelanotide Revenue Market Share by Region in Percentage: 2023 Versus 2030
  • Figure 14. Global Afamelanotide Revenue Market Share by Region (2019-2030)
  • Figure 15. Global Afamelanotide Sales 2019-2030 ((K Units)
  • Figure 16. Global Afamelanotide Sales Market Share by Region (2019-2030)
  • Figure 17. US & Canada Afamelanotide Sales YoY (2019-2030) & (K Units)
  • Figure 18. US & Canada Afamelanotide Revenue YoY (2019-2030) & (US$ Million)
  • Figure 19. Europe Afamelanotide Sales YoY (2019-2030) & (K Units)
  • Figure 20. Europe Afamelanotide Revenue YoY (2019-2030) & (US$ Million)
  • Figure 21. China Afamelanotide Sales YoY (2019-2030) & (K Units)
  • Figure 22. China Afamelanotide Revenue YoY (2019-2030) & (US$ Million)
  • Figure 23. Asia (excluding China) Afamelanotide Sales YoY (2019-2030) & (K Units)
  • Figure 24. Asia (excluding China) Afamelanotide Revenue YoY (2019-2030) & (US$ Million)
  • Figure 25. Middle East, Africa and Latin America Afamelanotide Sales YoY (2019-2030) & (K Units)
  • Figure 26. Middle East, Africa and Latin America Afamelanotide Revenue YoY (2019-2030) & (US$ Million)
  • Figure 27. The Afamelanotide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
  • Figure 28. The Top 5 and 10 Largest Manufacturers of Afamelanotide in the World: Market Share by Afamelanotide Revenue in 2023
  • Figure 29. Global Afamelanotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
  • Figure 30. Global Afamelanotide Sales Market Share by Type (2019-2030)
  • Figure 31. Global Afamelanotide Revenue Market Share by Type (2019-2030)
  • Figure 32. Global Afamelanotide Sales Market Share by Application (2019-2030)
  • Figure 33. Global Afamelanotide Revenue Market Share by Application (2019-2030)
  • Figure 34. US & Canada Afamelanotide Sales Market Share by Type (2019-2030)
  • Figure 35. US & Canada Afamelanotide Revenue Market Share by Type (2019-2030)
  • Figure 36. US & Canada Afamelanotide Sales Market Share by Application (2019-2030)
  • Figure 37. US & Canada Afamelanotide Revenue Market Share by Application (2019-2030)
  • Figure 38. US & Canada Afamelanotide Revenue Share by Country (2019-2030)
  • Figure 39. US & Canada Afamelanotide Sales Share by Country (2019-2030)
  • Figure 40. U.S. Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 41. Canada Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 42. Europe Afamelanotide Sales Market Share by Type (2019-2030)
  • Figure 43. Europe Afamelanotide Revenue Market Share by Type (2019-2030)
  • Figure 44. Europe Afamelanotide Sales Market Share by Application (2019-2030)
  • Figure 45. Europe Afamelanotide Revenue Market Share by Application (2019-2030)
  • Figure 46. Europe Afamelanotide Revenue Share by Country (2019-2030)
  • Figure 47. Europe Afamelanotide Sales Share by Country (2019-2030)
  • Figure 48. Germany Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 49. France Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 50. U.K. Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 51. Italy Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 52. Russia Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 53. China Afamelanotide Sales Market Share by Type (2019-2030)
  • Figure 54. China Afamelanotide Revenue Market Share by Type (2019-2030)
  • Figure 55. China Afamelanotide Sales Market Share by Application (2019-2030)
  • Figure 56. China Afamelanotide Revenue Market Share by Application (2019-2030)
  • Figure 57. Asia Afamelanotide Sales Market Share by Type (2019-2030)
  • Figure 58. Asia Afamelanotide Revenue Market Share by Type (2019-2030)
  • Figure 59. Asia Afamelanotide Sales Market Share by Application (2019-2030)
  • Figure 60. Asia Afamelanotide Revenue Market Share by Application (2019-2030)
  • Figure 61. Asia Afamelanotide Revenue Share by Region (2019-2030)
  • Figure 62. Asia Afamelanotide Sales Share by Region (2019-2030)
  • Figure 63. Japan Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 64. South Korea Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 65. China Taiwan Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 66. Southeast Asia Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 67. India Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 68. Middle East, Africa and Latin America Afamelanotide Sales Market Share by Type (2019-2030)
  • Figure 69. Middle East, Africa and Latin America Afamelanotide Revenue Market Share by Type (2019-2030)
  • Figure 70. Middle East, Africa and Latin America Afamelanotide Sales Market Share by Application (2019-2030)
  • Figure 71. Middle East, Africa and Latin America Afamelanotide Revenue Market Share by Application (2019-2030)
  • Figure 72. Middle East, Africa and Latin America Afamelanotide Revenue Share by Country (2019-2030)
  • Figure 73. Middle East, Africa and Latin America Afamelanotide Sales Share by Country (2019-2030)
  • Figure 74. Brazil Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 75. Mexico Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 76. Turkey Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 77. Israel Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 78. GCC Countries Afamelanotide Revenue (2019-2030) & (US$ Million)
  • Figure 79. Afamelanotide Value Chain
  • Figure 80. Afamelanotide Production Process
  • Figure 81. Channels of Distribution
  • Figure 82. Distributors Profiles
  • Figure 83. Bottom-up and Top-down Approaches for This Report
  • Figure 84. Data Triangulation
  • Figure 85. Key Executives Interviewed
目次

This research report focuses on the Afamelanotide Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Afamelanotide Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Afamelanotide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 SFM Implantation Cannula
    • 1.2.3 other implantation devices
  • 1.3 Market by Application
    • 1.3.1 Global Afamelanotide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Chemical
    • 1.3.3 Medical
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Afamelanotide Sales Estimates and Forecasts 2019-2030
  • 2.2 Global Afamelanotide Revenue by Region
    • 2.2.1 Global Afamelanotide Revenue by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Global Afamelanotide Revenue by Region (2019-2024)
    • 2.2.3 Global Afamelanotide Revenue by Region (2025-2030)
    • 2.2.4 Global Afamelanotide Revenue Market Share by Region (2019-2030)
  • 2.3 Global Afamelanotide Sales Estimates and Forecasts 2019-2030
  • 2.4 Global Afamelanotide Sales by Region
    • 2.4.1 Global Afamelanotide Sales by Region: 2019 VS 2023 VS 2030
    • 2.4.2 Global Afamelanotide Sales by Region (2019-2024)
    • 2.4.3 Global Afamelanotide Sales by Region (2025-2030)
    • 2.4.4 Global Afamelanotide Sales Market Share by Region (2019-2030)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Afamelanotide Sales by Manufacturers
    • 3.1.1 Global Afamelanotide Sales by Manufacturers (2019-2024)
    • 3.1.2 Global Afamelanotide Sales Market Share by Manufacturers (2019-2024)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Afamelanotide in 2023
  • 3.2 Global Afamelanotide Revenue by Manufacturers
    • 3.2.1 Global Afamelanotide Revenue by Manufacturers (2019-2024)
    • 3.2.2 Global Afamelanotide Revenue Market Share by Manufacturers (2019-2024)
    • 3.2.3 Global Top 10 and Top 5 Companies by Afamelanotide Revenue in 2023
  • 3.3 Global Key Players of Afamelanotide, Industry Ranking, 2022 VS 2023 VS 2024
  • 3.4 Global Afamelanotide Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Afamelanotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Afamelanotide, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Afamelanotide, Product Offered and Application
  • 3.8 Global Key Manufacturers of Afamelanotide, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Afamelanotide Sales by Type
    • 4.1.1 Global Afamelanotide Historical Sales by Type (2019-2024)
    • 4.1.2 Global Afamelanotide Forecasted Sales by Type (2025-2030)
    • 4.1.3 Global Afamelanotide Sales Market Share by Type (2019-2030)
  • 4.2 Global Afamelanotide Revenue by Type
    • 4.2.1 Global Afamelanotide Historical Revenue by Type (2019-2024)
    • 4.2.2 Global Afamelanotide Forecasted Revenue by Type (2025-2030)
    • 4.2.3 Global Afamelanotide Revenue Market Share by Type (2019-2030)
  • 4.3 Global Afamelanotide Price by Type
    • 4.3.1 Global Afamelanotide Price by Type (2019-2024)
    • 4.3.2 Global Afamelanotide Price Forecast by Type (2025-2030)

5 Market Size by Application

  • 5.1 Global Afamelanotide Sales by Application
    • 5.1.1 Global Afamelanotide Historical Sales by Application (2019-2024)
    • 5.1.2 Global Afamelanotide Forecasted Sales by Application (2025-2030)
    • 5.1.3 Global Afamelanotide Sales Market Share by Application (2019-2030)
  • 5.2 Global Afamelanotide Revenue by Application
    • 5.2.1 Global Afamelanotide Historical Revenue by Application (2019-2024)
    • 5.2.2 Global Afamelanotide Forecasted Revenue by Application (2025-2030)
    • 5.2.3 Global Afamelanotide Revenue Market Share by Application (2019-2030)
  • 5.3 Global Afamelanotide Price by Application
    • 5.3.1 Global Afamelanotide Price by Application (2019-2024)
    • 5.3.2 Global Afamelanotide Price Forecast by Application (2025-2030)

6 US & Canada

  • 6.1 US & Canada Afamelanotide Market Size by Type
    • 6.1.1 US & Canada Afamelanotide Sales by Type (2019-2030)
    • 6.1.2 US & Canada Afamelanotide Revenue by Type (2019-2030)
  • 6.2 US & Canada Afamelanotide Market Size by Application
    • 6.2.1 US & Canada Afamelanotide Sales by Application (2019-2030)
    • 6.2.2 US & Canada Afamelanotide Revenue by Application (2019-2030)
  • 6.3 US & Canada Afamelanotide Market Size by Country
    • 6.3.1 US & Canada Afamelanotide Revenue by Country: 2019 VS 2023 VS 2030
    • 6.3.2 US & Canada Afamelanotide Sales by Country (2019-2030)
    • 6.3.3 US & Canada Afamelanotide Revenue by Country (2019-2030)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Afamelanotide Market Size by Type
    • 7.1.1 Europe Afamelanotide Sales by Type (2019-2030)
    • 7.1.2 Europe Afamelanotide Revenue by Type (2019-2030)
  • 7.2 Europe Afamelanotide Market Size by Application
    • 7.2.1 Europe Afamelanotide Sales by Application (2019-2030)
    • 7.2.2 Europe Afamelanotide Revenue by Application (2019-2030)
  • 7.3 Europe Afamelanotide Market Size by Country
    • 7.3.1 Europe Afamelanotide Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 Europe Afamelanotide Sales by Country (2019-2030)
    • 7.3.3 Europe Afamelanotide Revenue by Country (2019-2030)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Afamelanotide Market Size
    • 8.1.1 China Afamelanotide Sales (2019-2030)
    • 8.1.2 China Afamelanotide Revenue (2019-2030)
  • 8.2 China Afamelanotide Market Size by Application
    • 8.2.1 China Afamelanotide Sales by Application (2019-2030)
    • 8.2.2 China Afamelanotide Revenue by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Afamelanotide Market Size by Type
    • 9.1.1 Asia Afamelanotide Sales by Type (2019-2030)
    • 9.1.2 Asia Afamelanotide Revenue by Type (2019-2030)
  • 9.2 Asia Afamelanotide Market Size by Application
    • 9.2.1 Asia Afamelanotide Sales by Application (2019-2030)
    • 9.2.2 Asia Afamelanotide Revenue by Application (2019-2030)
  • 9.3 Asia Afamelanotide Sales by Region
    • 9.3.1 Asia Afamelanotide Revenue by Region: 2019 VS 2023 VS 2030
    • 9.3.2 Asia Afamelanotide Revenue by Region (2019-2030)
    • 9.3.3 Asia Afamelanotide Sales by Region (2019-2030)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Afamelanotide Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Afamelanotide Sales by Type (2019-2030)
    • 10.1.2 Middle East, Africa and Latin America Afamelanotide Revenue by Type (2019-2030)
  • 10.2 Middle East, Africa and Latin America Afamelanotide Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Afamelanotide Sales by Application (2019-2030)
    • 10.2.2 Middle East, Africa and Latin America Afamelanotide Revenue by Application (2019-2030)
  • 10.3 Middle East, Africa and Latin America Afamelanotide Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Afamelanotide Revenue by Country: 2019 VS 2023 VS 2030
    • 10.3.2 Middle East, Africa and Latin America Afamelanotide Revenue by Country (2019-2030)
    • 10.3.3 Middle East, Africa and Latin America Afamelanotide Sales by Country (2019-2030)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Clinuvel Pharmaceuticals
    • 11.1.1 Clinuvel Pharmaceuticals Company Information
    • 11.1.2 Clinuvel Pharmaceuticals Overview
    • 11.1.3 Clinuvel Pharmaceuticals Afamelanotide Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.1.4 Clinuvel Pharmaceuticals Afamelanotide Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Clinuvel Pharmaceuticals Recent Developments
  • 11.2 Aspen API
    • 11.2.1 Aspen API Company Information
    • 11.2.2 Aspen API Overview
    • 11.2.3 Aspen API Afamelanotide Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.2.4 Aspen API Afamelanotide Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Aspen API Recent Developments
  • 11.3 Jin Dun Medical
    • 11.3.1 Jin Dun Medical Company Information
    • 11.3.2 Jin Dun Medical Overview
    • 11.3.3 Jin Dun Medical Afamelanotide Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.3.4 Jin Dun Medical Afamelanotide Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Jin Dun Medical Recent Developments
  • 11.4 Winhealth Pharma
    • 11.4.1 Winhealth Pharma Company Information
    • 11.4.2 Winhealth Pharma Overview
    • 11.4.3 Winhealth Pharma Afamelanotide Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.4.4 Winhealth Pharma Afamelanotide Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Winhealth Pharma Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Afamelanotide Industry Chain Analysis
  • 12.2 Afamelanotide Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Afamelanotide Production Mode & Process
  • 12.4 Afamelanotide Sales and Marketing
    • 12.4.1 Afamelanotide Sales Channels
    • 12.4.2 Afamelanotide Distributors
  • 12.5 Afamelanotide Customers

13 Market Dynamics

  • 13.1 Afamelanotide Industry Trends
  • 13.2 Afamelanotide Market Drivers
  • 13.3 Afamelanotide Market Challenges
  • 13.4 Afamelanotide Market Restraints

14 Key Findings in The Global Afamelanotide Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer